The change aims to improve safety standards and reduce infection risks, following concerns over the quality of certain blood ...

Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...

A recent study led by Prof. Chen Yaning from the Xinjiang Institute of Ecology and Geography (XIEG) of the Chinese Academy of ...

Kochi: Denial of public employment to a job aspirant solely on the ground that the individual is afflicted with Hepatitis B ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

Ministry of Health and Family Welfare intensifies efforts to prevent Hepatitis B transmission from mother to child by ...

As global markets navigate the complexities of renewed tariff threats and economic uncertainties, investors are increasingly turning their attention to Asia, where growth companies with high insider ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...